Welcome to the e-CCO Library!

P621: Secure Electronic Document Signing Uptake in Biologic Prescribing for Immune Mediate Diseases
Year: 2022
Source: ECCO'22
Authors: Sharma, S.(1);Jones, J.(1);Stewart, M.(1);
Created: Friday, 11 February 2022, 3:56 PM
P622 Recovery of nutrient deficiency as a predictor of remission in inflammatory bowel diseases
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.A. Iakovlev, A. Volkov, I. Shcherbakova, G. Leonova, V. Piskovets

Created: Thursday, 30 January 2020, 10:12 AM
P622: Change in Dietary Inflammatory Index Score in patients with Crohn's disease and healthy volunteers following the Groningen Anti Inflammatory Diet (GrAID)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: BarthDrs., I.(1)*;Stevens, C.L.(1);Campmans-Kuijpers, M.J.E.(1);Dijkstra, G.(1);
Created: Friday, 14 July 2023, 11:05 AM
P622: Child outcome in IBD pregnancy: early vs. late discontinuation of IFX therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Truta*1, T. Bayless1, J. Canner1, S. Bashar1

Created: Friday, 22 February 2019, 9:41 AM
P622: Comparison of long-term outcomes of infliximab and adalimumab in biologic-naïve patients with ulcerative colitis
Year: 2022
Source: ECCO'22
Authors: Durak, M.B.(1);Baspınar, B.(1);Guven, I.E.(1);Kivrakoglu, F.(1,2);Kilic, V.(1);Kosar, K.(1);Erdogan, C.(1);Yüksel, I.(1,2);
Created: Friday, 11 February 2022, 3:56 PM
P622: Comparison of midterm outcomes in Pediatric Crohn’s Disease patients treated with either Exclusive Enteral Nutrition or Corticosteroids around disease diagnosis– a population based study
Year: 2021
Source: ECCO'21 Virtual
Authors: Plotkin, L.(1);Focht, G.(1);Harel, S.(1);Dotan, I.(2);Greenfeld, S.(3);Kariv, R.(3);Gabay, H.(4);Loewenberg Weisband, Y.(4);Turner, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P622: Efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Derwa Y.1, Gracie D.J.*1,2, Hamlin P.J.1, Ford A.C.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P623 Cumulative incidence of infliximab use after a first flare of acute severe colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. GHRIBI, G. Mohamed, S. Bizid, B. Ben Sliman, K. Boughoula, H. Ben Abdallah, R. Bouali, M.N. Abdelli

Created: Thursday, 30 January 2020, 10:12 AM
P623: Colorectal cancer, colectomy rates and inflammatory bowel disease activity following liver transplantation in primary sclerosing cholangitis: a systematic review and meta-analysis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Thomas*1, R. Cooney2, T. Iqbal2,3, S. Ghosh2,3, J. Ferguson3,4, G. Hirschfield5, P. Trivedi3,4,6,7

Created: Friday, 22 February 2019, 9:41 AM
P623: Mucosal eosinophils as markers of post-induction vedolizumab response in paediatric Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Musto, F.(1)*;Ranalli, M.(2);Giordano, C.(3);Bianchi, E.(2);Veraldi, S.(4);Oliva, S.(5);D'Arcangelo, G.(2);Aloi, M.(2);
Created: Friday, 14 July 2023, 11:05 AM
P623: Quality of life as predictor of biological levels decay in inflammatory bowel diseases
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Ceballos1*, M.D. Fiuza2, I. Alarcón3

Created: Thursday, 21 February 2019, 9:14 AM
P623: The effectiveness and tolerability of Crohn’s disease exclusion diet in adult Crohn’s disease patients: a retrospective study
Year: 2022
Source: ECCO'22
Authors: Mahajna, H.(1);Abu-Salah, R.(1);Tzur, M.(1);Kedar, N.(1);Ben-Horin, S.(1);Kopylov, U.(1);Engel, T.(1);
Created: Friday, 11 February 2022, 3:56 PM
P623: The impact of SARS-CoV-2 outbreak on the treatment adherence and clinical outcome of patients with inflammatory bowel disease treated with biological agents.
Year: 2021
Source: ECCO'21 Virtual
Authors: Martino, G.(1);Carparelli, S.(1);Marseglia, A.(2);Pastore, M.R.(2);Placentino, M.(3);Nardella, M.(1);Guerra, M.(1);Palmieri, O.(1);Latiano, A.(1);Perri, F.(1);Ercolino, F.(1);Bossa, F.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P623: Therapeutic preferences and outcomes in newly diagnosed patient with inflammatory bowel diseases in the biological era in Hungary. A nationwide study based on the National Health Insurance Fund database
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gonczi L.*1, Vegh Z.1, Kurti Z.1, Lovasz B.D.1, Golovics P.A.1, Fadgyas-Freyler P.2, Gimesi-Orszagh J.2, Gecse K.B.1, Lakatos P.L.1

Created: Wednesday, 20 February 2019, 10:36 AM
P624 Maintenance of remission after treatment with Exclusive Enteral Nutrition and Azathioprine in paediatric patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Pujol Muncunill, A.I. Pascual-Pérez, P. Dominguez-Sánchez, S. Feo-Ortega, M. Suárez-Galvis, V. Vila-Miravet, F.J. Martin de Carpi

Created: Thursday, 30 January 2020, 10:12 AM
P624: A higher prevalence of human papillomavirus in patients with perianal fistulizing Crohn's disease compared to patients with anorectal fistula without Crohn's disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Rodrigues Boarini, L.(1);Sobrado Jr, C.W.(1);Facanali, C.B.G.(1);Queiroz, N.S.F.(1);Albuquerque, I.C.(2);Boarini, P.(3);Boarini, M.R.(4);Borba, M.R.(1);Nahas, S.C.(1);Cecconello, I.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P624: Chromoendoscopy and narrow band imaging versus conventional white light endoscopy for detection of neoplasia in ulcerative colitis – a systematic review and meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Har-Noy O.1, Katz L.1, Avni T.2, Bessissow T.3, Young D.4, Koulaouzidis A.4, Engel T.1, Eliakim R.1, Ben-Horin S.1, Kopylov U.*5

Created: Wednesday, 20 February 2019, 10:36 AM
P624: Factors that may influence the development of anti-drug antibodies to adalimumab
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. Reinisch*1, I. Rauter2, L. Chen3, M. Gessner3, G. Fanjiang3

Created: Friday, 22 February 2019, 9:41 AM
P624: Investigating the symptom burden among European patients with moderate-to-severe Crohn's disease using a real-world survey
Year: 2023
Source: ECCO’23 Copenhagen
Authors: BurischPhD, J.(1)*;Hart, A.(2);Sturm, A.(3);Knight, H.(4);Rudolph, C.(5);Meadows, R.(4);Oortwijn, A.(5);Weatherby, S.(4);Rolph, R.(6);Dawod, F.(4);Armuzzi, A.(7);
Created: Friday, 14 July 2023, 11:05 AM